Achiko Past Earnings Performance
Past criteria checks 0/6
Achiko has been growing earnings at an average annual rate of 51%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been declining at an average rate of 82.7% per year.
Key information
51.0%
Earnings growth rate
61.3%
EPS growth rate
| Biotechs Industry Growth | 18.9% |
| Revenue growth rate | -82.7% |
| Return on equity | n/a |
| Net Margin | -27,885.0% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Achiko makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 0 | -7 | 4 | 0 |
| 31 Mar 22 | 0 | -8 | 5 | 1 |
| 31 Dec 21 | 0 | -9 | 6 | 1 |
| 30 Sep 21 | 0 | -12 | 8 | 1 |
| 30 Jun 21 | 0 | -14 | 10 | 1 |
| 31 Mar 21 | 1 | -14 | 11 | 1 |
| 31 Dec 20 | 3 | -14 | 12 | 1 |
| 30 Sep 20 | 4 | -13 | 11 | 0 |
| 30 Jun 20 | 6 | -11 | 11 | 0 |
| 31 Mar 20 | 6 | -9 | 9 | 0 |
| 31 Dec 19 | 6 | -7 | 6 | 0 |
| 30 Jun 19 | 8 | -8 | 3 | 0 |
| 31 Mar 19 | 7 | -7 | 3 | 0 |
| 31 Dec 18 | 5 | -7 | 3 | 0 |
Quality Earnings: ACHI is currently unprofitable.
Growing Profit Margin: ACHI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ACHI's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ACHI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACHI is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-26.8%).
Return on Equity
High ROE: ACHI's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.